Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	19.36	17.4	38.64	117.76	70.44	62.26
Short-Term Investments	-	8.97	20.53	-	-	41.89
Cash & Short-Term Investments	19.36	26.37	59.17	117.76	70.44	104.15
Cash Growth	-56.79%	-55.44%	-49.76%	67.19%	-32.37%	-18.70%
Accounts Receivable	0.37	0.57	5.81	3.31	1.71	6.79
Other Receivables	0.51	5.47	5.23	-	-	-
Receivables	0.88	6.04	11.04	3.31	1.71	6.79
Prepaid Expenses	0.28	4.09	3.21	6.55	3.58	4.07
Other Current Assets	-	2.19	-	-	-	-
Total Current Assets	20.52	38.68	73.42	127.63	75.72	115.01
Property, Plant & Equipment	-	-	20.7	23.03	25.98	22.94
Other Long-Term Assets	-	-	1.37	2.9	3.31	3.15
Total Assets	20.52	38.68	95.49	153.56	105.01	141.1
Accounts Payable	0.8	3.37	4.15	8.61	1.79	5.8
Accrued Expenses	3.45	7.97	10.02	12.24	5.98	8.69
Current Portion of Leases	-	-	0.86	1.05	1.03	0.73
Current Unearned Revenue	-	-	20.82	25.12	12.63	11.26
Other Current Liabilities	-	0.58	0.73	3.54	0.72	0.52
Total Current Liabilities	4.25	11.92	36.58	50.56	22.15	27
Long-Term Leases	-	-	12.24	13.84	15.93	15.48
Long-Term Unearned Revenue	-	-	18.73	38.4	35.9	47.26
Other Long-Term Liabilities	-	-	-	-	0.01	-
Total Liabilities	4.25	11.92	67.56	102.81	73.98	89.75
Common Stock	0	0.1	0.07	0.07	0.06	0.06
Additional Paid-In Capital	342.92	341.6	318.53	307	242.67	227.47
Retained Earnings	-326.33	-314.96	-290.42	-257.14	-211.41	-174.18
Comprehensive Income & Other	-0.32	0.03	-0.25	0.83	-0.3	-2
Shareholders' Equity	16.27	26.76	27.93	50.76	31.03	51.35
Total Liabilities & Equity	20.52	38.68	95.49	153.56	105.01	141.1
Total Debt	-	-	13.1	14.89	16.96	16.22
Net Cash (Debt)	19.36	26.37	46.07	102.87	53.47	87.94
Net Cash Growth	-40.45%	-42.76%	-55.22%	92.38%	-39.19%	-31.36%
Net Cash Per Share	15.21	23.42	49.69	127.50	78.52	138.96
Filing Date Shares Outstanding	1.32	1.24	0.93	0.93	0.75	0.69
Total Common Shares Outstanding	1.32	1.24	0.93	0.9	0.7	0.69
Working Capital	16.27	26.76	36.84	77.06	53.58	88.01
Book Value Per Share	12.32	21.64	29.98	56.22	44.32	74.41
Tangible Book Value	16.27	26.76	27.93	50.76	31.03	51.35
Tangible Book Value Per Share	12.32	21.64	29.98	56.22	44.32	74.41
Machinery	-	-	14.2	13.71	13.7	12.36
Leasehold Improvements	-	-	12.44	13.13	14.16	10.71

Source: S&P Capital IQ. Standard template. Financial Sources.